Bent Frandsen — CEO
Get alerts when Bent Frandsen trades
Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: ExpreS2ion Biotech Holding AB.
12-month summary
Net buyer over the last 12 months
3 open-market buys, 0 sales, 1 share award · SEK 34,480.00 bought, SEK 0.00 sold
Roles
02.10.2025 – 09.10.2026
Transactions (including via associated entities)
| Date | Issuer | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 09.10.2026 | ExpreS2ion Biotech Holding AB Stockholm | Bought — open marketAcquisition | 10,000 | SEK 1.10 | SEK 11,000.00 | ↗ |
| 02.10.2026 | ExpreS2ion Biotech Holding AB Stockholm | Bought — open marketAcquisition | 8,000 | SEK 1.15 | SEK 9,200.00 | ↗ |
| 01.10.2026 | ExpreS2ion Biotech Holding AB Stockholm | Bought — open marketAcquisition | 12,000 | SEK 1.19 | SEK 14,280.00 | ↗ |
| 01.07.2026 | ExpreS2ion Biotech Holding AB Stockholm | Share award | 356,234 | — | Share award 356,234 units | ↗ |
| 01.05.2026 | ExpreS2ion Biotech Holding AB Stockholm | New shares (subscription) | 156,250 | SEK 1.60 | SEK 250,000.00 | ↗ |
| 20.04.2026 | ExpreS2ion Biotech Holding AB Stockholm | SoldDisposal | 192,125 | SEK 0.00 | SEK 461.10 | ↗ |
| 20.04.2026 | ExpreS2ion Biotech Holding AB Stockholm | SoldDisposal | 477 | SEK 0.01 | SEK 5.25 | ↗ |
| 20.04.2026 | ExpreS2ion Biotech Holding AB Stockholm | SoldDisposal | 121,230 | SEK 0.01 | SEK 1,236.55 | ↗ |
| 20.04.2026 | ExpreS2ion Biotech Holding AB Stockholm | SoldDisposal | 76,158 | SEK 0.01 | SEK 807.27 | ↗ |
| 20.04.2026 | ExpreS2ion Biotech Holding AB Stockholm | SoldDisposal | 56,588 | SEK 0.01 | SEK 577.20 | ↗ |
| 02.10.2025 | ExpreS2ion Biotech Holding AB Stockholm | Option exercise | 4,920 | SEK 14.65 | SEK 72,078.00 | ↗ |
| 02.10.2025 | ExpreS2ion Biotech Holding AB Stockholm | Option exercise | 196,800 | SEK 14.65 | SEK 2,883,120.00 | ↗ |